OrganiGram Holdings Inc. has seen a significant rise in its stock price, reflecting investor confidence after strong quarterly results.
In the latest trading session, OrganiGram Holdings Inc (OGI.TO) gained 2.03%, closing at CA$1.51. This positive movement follows the company's announcement of record revenues, demonstrating its solid position in the cannabis market.
Investor takeaway: Investors are responding positively to OrganiGram's strong financial performance and strategic initiatives, indicating potential growth in the competitive cannabis sector.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
OrganiGram Holdings Inc
OGI.TO
OGI.TO
OrganiGram Holdings Inc
WealthAwesomeMarket cap
$192.86M
52W high
$3.09
52W low
$1.32
1W change
-5.52%
Beta
1.85
Analyst Price Targets
Based on analyst covering OGI
Wall Street analysts forecast OGI stock price to rise 117.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.98
+117.5% Upside
Current Price
C$1.37
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on OGI's historical volatility
30-Day Vol
35.6%
Annualized
90-Day Vol
53.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.15
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$1.29 | C$1.14 โ C$1.46 |
| 60 trading days | C$1.22 | C$1.02 โ C$1.45 |
| 90 trading days | C$1.15 | C$0.93 โ C$1.42 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
OrganiGram's Revenue Soars by 73% Year-Over-Year
The company reported a record gross revenue of $110.2 million for Q3 Fiscal 2025, showcasing its growth trajectory in a competitive landscape.
Bull case
The recent record gross revenue of $110.2 million for Q3 Fiscal 2025, a remarkable 73% increase year-over-year, shows that OrganiGram is effectively capturing market share and improving its operational efficiency.
Bear case
Despite the positive revenue growth, the company is still operating at a loss with a profit margin of -9.2%. This raises concerns about its long-term profitability and sustainability.
Strong Financial Results Boost Investor Confidence
OrganiGram's announcement of record gross revenue of $110.2 million for Q3 Fiscal 2025 has significantly boosted investor confidence. This 73% year-over-year increase highlights the company's ability to thrive in a competitive market, attracting more attention from investors seeking growth opportunities. For more insights, check out the full report on OrganiGram's performance.
Market Dynamics and Future Outlook
The cannabis market is continually evolving, and OrganiGram's strategic initiatives, including its recent share consolidation and partnerships, position it well for future growth. Investors should stay alert about the company's profit margins and operational efficiency as they navigate this dynamic landscape. Learn more about OrganiGram's market strategies in our detailed analysis here.
Advertisement
